Instead of saying how long one can survive, small liver cancer is usually described by the five-year survival rate, which refers to the percentage of cancer patients who survive more than five years after treatment. The five-year survival rate of small liver cancer patients with active treatment can reach about 60% to 80%, which varies from person to person. Clinically, tumors with single diameter ≤3 or the sum of two diameters ≤3cm are often called small liver cancers, which are mainly related to cirrhosis & viral hepatitis and other chronic liver injuries, and manifested as pain in the liver area, nausea and vomiting, ascites and other symptoms. The best treatment for 2cm small hepatocellular carcinoma at present is surgical resection, which reduces the trauma through laparoscopic surgery and is favorable to the patient’s recovery and postoperative care. If the patient’s physical condition is poor enough to withstand surgery, local radiofrequency ablation, chemotherapy and TACE (hepatic artery chemoembolization) can be adopted. Therefore, patients with small liver cancer should choose the most appropriate treatment according to their individual conditions under the guidance of their doctors. Although the five-year survival rate of small hepatocellular carcinoma patients can reach 60% to 80%, postoperative recurrence is still relatively common, and can be combined with interventional therapy or medication in the course of treatment. In daily life, patients should ensure sufficient nutrition and sleep, avoid drinking alcohol and consume more fresh fruits and vegetables. Regular checkups should be conducted in the hospital, and if there is any discomfort, consult a doctor immediately.